13 days ago
5
0
Posted On: October 23rd 2026, 05:04 pm
Ozempic. Mounjaro. Retatrutide. What's actually the difference?
You've probably heard of Ozempic and Mounjaro. But there's another name getting a lot of attention in weight-loss research: retatrutide.
Here's what makes them different. 👇
1️⃣ Ozempic (semaglutide): ONE hormone pathway
Ozempic works by mimicking GLP-1, a hormone that helps regulate blood sugar, appetite, and how quickly food leaves your stomach.
Think of it as working through one key hormone pathway.
2️⃣ Mounjaro (tirzepatide): TWO hormone pathways
Mounjaro takes a different approach by targeting TWO hormone pathways:
• GLP-1: Helps regulate appetite and blood sugar.
• GIP: Works alongside GLP-1 to influence insulin response and metabolism.
Both Ozempic and Mounjaro are FDA-approved for type 2 diabetes. Their active ingredients are also used in FDA-approved weight-management medications called Wegovy and Zepbound.
3️⃣ Retatrutide: THREE hormone pathways
This is where the research gets interesting.
Retatrutide is an investigational medication that targets:
• GLP-1
• GIP
• Glucagon: A hormone involved in regulating blood sugar and energy metabolism.
In a Phase 3 clinical trial, participants receiving the highest studied dose lost an average of 28.3% of their body weight over 80 weeks.
That's a significant finding, but it doesn't mean retatrutide is automatically better or safer than existing medications. Direct comparisons and continued safety research matter.
⚠️ Important: Retatrutide is NOT FDA-approved and is not legally available to consumers outside authorized clinical trials.
So what's the takeaway?
Researchers are exploring medications that act on multiple hormone pathways, potentially opening new possibilities for metabolic health.
But more hormone targets don't automatically mean a better treatment for everyone.
The right treatment depends on your health history, medical needs, and guidance from a qualified provider.
Had you heard of retatrutide before today? 👇
#GLP1 #Ozempic #Mounjaro #Retatrutide #Semaglutide #Tirzepatide #WeightLossResearch #PeptideScience #MetabolicHealth #PeptideMatch
You've probably heard of Ozempic and Mounjaro. But there's another name getting a lot of attention in weight-loss research: retatrutide.
Here's what makes them different. 👇
1️⃣ Ozempic (semaglutide): ONE hormone pathway
Ozempic works by mimicking GLP-1, a hormone that helps regulate blood sugar, appetite, and how quickly food leaves your stomach.
Think of it as working through one key hormone pathway.
2️⃣ Mounjaro (tirzepatide): TWO hormone pathways
Mounjaro takes a different approach by targeting TWO hormone pathways:
• GLP-1: Helps regulate appetite and blood sugar.
• GIP: Works alongside GLP-1 to influence insulin response and metabolism.
Both Ozempic and Mounjaro are FDA-approved for type 2 diabetes. Their active ingredients are also used in FDA-approved weight-management medications called Wegovy and Zepbound.
3️⃣ Retatrutide: THREE hormone pathways
This is where the research gets interesting.
Retatrutide is an investigational medication that targets:
• GLP-1
• GIP
• Glucagon: A hormone involved in regulating blood sugar and energy metabolism.
In a Phase 3 clinical trial, participants receiving the highest studied dose lost an average of 28.3% of their body weight over 80 weeks.
That's a significant finding, but it doesn't mean retatrutide is automatically better or safer than existing medications. Direct comparisons and continued safety research matter.
⚠️ Important: Retatrutide is NOT FDA-approved and is not legally available to consumers outside authorized clinical trials.
So what's the takeaway?
Researchers are exploring medications that act on multiple hormone pathways, potentially opening new possibilities for metabolic health.
But more hormone targets don't automatically mean a better treatment for everyone.
The right treatment depends on your health history, medical needs, and guidance from a qualified provider.
Had you heard of retatrutide before today? 👇
#GLP1 #Ozempic #Mounjaro #Retatrutide #Semaglutide #Tirzepatide #WeightLossResearch #PeptideScience #MetabolicHealth #PeptideMatch
More posts
